Avestar Capital, LLC Gsk PLC Transaction History

Avestar Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $53,204 - $57,228	-1,315 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$39.4 - $42.7 $78 - $85	2 Added 0.15%	1,315 $50,000
Q1 2019 May 09, 2019	BUY	$38.57 - $42.69 $33,478 - $37,054	868 Added 195.06%	1,313 $53,000
Q4 2018 Jan 25, 2019	SELL	$37.8 - $42.69 $14,363 - $16,222	-380 Reduced 46.06%	445 $14,000
Q3 2018 Oct 23, 2018	BUY	$39.75 - $42.69 $16,933 - $18,185	426 Added 106.77%	825 $31,000
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $3,683 - $3,976	93 Added 30.39%	399 $14,000
Q1 2018 May 10, 2018	SELL	$36.18 - $40.15 $13,350 - $14,815	-369 Reduced 54.67%	306 $9,000
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $23,854 - $28,282	675	675 $21,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.